Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma

Novartis Pharmaceuticals · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
krasmelanomanon-small-cell-lung-cancernsclc
non-small cell lung cancer, melanoma, nsclc, nras, kras, braf, lxh254, ltt462, trametinib, ribocliclib, non-small cell lung carcinoma (nsclc), treatment of lung cancer after first metastasis
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 833791
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.